The Who, What, When and Where of Inpatient Direct Oral Penicillin Challenge - Implications for health services implementation.

2023-07-05

Trubiano, Jason

Vogrin, S

Mitri, Elise A

Hall, R

Copaescu, Ana

Waldron, J

De Luca, J

Rose, Morgan T

Mackay, G

Lambros, B

Douglas, A P

Holmes, Natasha E

Chua, Kyra Y L

amoxicillin allergy

antimicrobial stewardship

beta-lactam allergy

drug allergy

oral provocation

Journal Article

0000-0002-5111-6367

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

#PLACEHOLDER_PARENT_METADATA_VALUE#

10.1093/cid/ciad156

Inpatient direct oral challenge programs are increasingly deployed as part of antimicrobial stewardship (AMS) initiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing. Using data from a prospective multicentre cohort inpatient penicillin allergy program, we identify the key targets for delabeling to aid health service implementation.

link

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 2023; 77(1)

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America

1537-6591